FIELD: biotechnology; medicine.
SUBSTANCE: disclosed is an isolated isoform of Atlantic cod trypsin ZT containing the amino acid sequence SEQ ID NO: 2 or amino acid sequence with sequence homology of 99% or more, a medical composition based thereon and a method of treating diseases caused by picornaviruses, which involves administering a therapeutically effective amount of the composition.
EFFECT: new isoform of trypsin ZT is better adapted for cleavage of peptides containing several sequential basic amino acid residues Arg and Lys, has specific antiviral activity.
11 cl, 5 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL TRYPSIN ISOFORMS AND USE THEREOF | 2016 |
|
RU2739945C2 |
| PORCINE TRYPSIN OPTIONS | 2019 |
|
RU2783315C2 |
| CD40L ANTIBODIES AND METHODS OF TREATING CD40L RELATED DISEASES AND DISORDERS | 2016 |
|
RU2727646C2 |
| IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS | 2019 |
|
RU2828590C2 |
| IL2 AND MUTANT TNF IMMUNOCONJUGATES | 2017 |
|
RU2758139C2 |
| ANTI-CD38 ANTIBODIES AND FORMULATIONS | 2020 |
|
RU2826957C2 |
| AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF | 2020 |
|
RU2826004C2 |
| FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
| CHIMERIC ANTIGEN RECEPTORS TARGETED TO FC RECEPTOR-LIKE PROTEIN 5, AND THEIR USE | 2015 |
|
RU2779747C2 |
| NGF ANTAGONISTS FOR MEDICAL USE | 2020 |
|
RU2829812C2 |
